发明授权
US07528136B2 Prolinamide derivatives as NK3 antagonists 失效
脯氨酰胺衍生物作为NK3拮抗剂

Prolinamide derivatives as NK3 antagonists
摘要:
The present invention relates to a compound of formula I wherein R1, R2, R3, R4, R5, X, n, and o are as defined herein and to a pharmaceutically acceptable acid addition salt thereof which are high potential NK-3 receptor antagonists for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder (ADHD).
公开/授权文献
信息查询
0/0